Cindy Woodland

793 total citations
23 papers, 640 citations indexed

About

Cindy Woodland is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Molecular Biology. According to data from OpenAlex, Cindy Woodland has authored 23 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Cindy Woodland's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Cindy Woodland is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Cindy Woodland collaborates with scholars based in Canada, United Kingdom and United States. Cindy Woodland's co-authors include Gideon Koren, Shinya Ito, Katarina Aleksa, Michael Rieder, Nancy Chen, Gideon Koren, Julia Klein, Patricia A. Harper, Deborah Kennedy and Irving W. Wainer and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Life Sciences.

In The Last Decade

Cindy Woodland

23 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cindy Woodland Canada 15 249 205 136 129 110 23 640
Tauri Senn United States 8 120 0.5× 158 0.8× 197 1.4× 233 1.8× 75 0.7× 8 603
Hany Ghabrial Australia 14 182 0.7× 204 1.0× 327 2.4× 22 0.2× 104 0.9× 47 767
William Cacini United States 12 89 0.4× 128 0.6× 43 0.3× 137 1.1× 144 1.3× 28 463
R Pelkonen Finland 19 166 0.7× 183 0.9× 341 2.5× 55 0.4× 117 1.1× 42 899
Sumío Hirata Japan 15 95 0.4× 83 0.4× 68 0.5× 80 0.6× 115 1.0× 59 657
Lance Cope United Kingdom 7 117 0.5× 110 0.5× 163 1.2× 25 0.2× 48 0.4× 11 709
R. A. Smallwood Australia 19 86 0.3× 237 1.2× 125 0.9× 22 0.2× 91 0.8× 43 934
E. W�hlin-Boll Sweden 17 138 0.6× 57 0.3× 82 0.6× 33 0.3× 93 0.8× 24 798
Yacoub M. Irshaid Jordan 13 86 0.3× 139 0.7× 263 1.9× 70 0.5× 163 1.5× 48 697
Xiao‐cong Zuo China 16 137 0.6× 81 0.4× 99 0.7× 35 0.3× 130 1.2× 59 929

Countries citing papers authored by Cindy Woodland

Since Specialization
Citations

This map shows the geographic impact of Cindy Woodland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Woodland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Woodland more than expected).

Fields of papers citing papers by Cindy Woodland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Woodland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Woodland. The network helps show where Cindy Woodland may publish in the future.

Co-authorship network of co-authors of Cindy Woodland

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Woodland. A scholar is included among the top collaborators of Cindy Woodland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Woodland. Cindy Woodland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aleksa, Katarina, et al.. (2008). N ‐Acetylcysteine prevents ifosfamide‐induced nephrotoxicity in rats. British Journal of Pharmacology. 153(7). 1364–1372. 63 indexed citations
2.
Woodland, Cindy, et al.. (2008). Expression, Activity and Regulation of CYP3A in Human and Rodent Brain. Drug Metabolism Reviews. 40(1). 149–168. 37 indexed citations
3.
Chen, Nancy, Katarina Aleksa, Cindy Woodland, Michael Rieder, & Gideon Koren. (2007). Prevention of ifosfamide nephrotoxicity by N-acetylcysteine: clinical pharmacokinetic considerations.. PubMed. 14(2). e246–50. 6 indexed citations
4.
Chen, Nancy, Katarina Aleksa, Cindy Woodland, Michael Rieder, & Gideon Koren. (2007). The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells. Translational research. 150(1). 51–57. 39 indexed citations
5.
Shuey, Dana, et al.. (2006). Oxymorphone Hydrochloride, a Potent Opioid Analgesic, Is Not Carcinogenic in Rats or Mice. Toxicological Sciences. 96(1). 162–173. 8 indexed citations
6.
Halachmi, Naomi, et al.. (2005). Ontogeny of Renal P-glycoprotein Expression in Mice: Correlation with Digoxin Renal Clearance. Pediatric Research. 58(6). 1284–1289. 14 indexed citations
7.
Chen, Nancy, Katarina Aleksa, Cindy Woodland, Michael Rieder, & Gideon Koren. (2005). Ontogeny of drug elimination by the human kidney. Pediatric Nephrology. 21(2). 160–168. 102 indexed citations
8.
Kalra, Sanjog, Julia Klein, Tatyana Karaskov, et al.. (2005). Use of hair cortisol as a biomarker for chronic stress in pregnancy. Clinical Pharmacology & Therapeutics. 77(2). P69–P69. 9 indexed citations
9.
Woodland, Cindy, et al.. (2003). Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents. Canadian Journal of Physiology and Pharmacology. 81(8). 800–805. 14 indexed citations
10.
Woodland, Cindy, Gideon Koren, & Shinya Ito. (2003). From Bench to Bedside: Utilization of an In Vitro Model to Predict Potential Drug‐Drug Interactions in the Kidney: The Digoxin‐Mifepristone Example. The Journal of Clinical Pharmacology. 43(7). 743–750. 7 indexed citations
11.
Boskovic, Rada, et al.. (2001). The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: A twin study. Canadian Journal of Physiology and Pharmacology. 79(11). 942–945. 4 indexed citations
12.
Aleksa, Katarina, Cindy Woodland, & Gideon Koren. (2001). Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies. Pediatric Nephrology. 16(12). 1153–1158. 27 indexed citations
13.
Boskovic, Rada, et al.. (2001). The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: A twin study. Canadian Journal of Physiology and Pharmacology. 79(11). 942–945. 30 indexed citations
14.
Woodland, Cindy, Shinya Ito, Camille Granvil, et al.. (2000). Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. Life Sciences. 68(1). 109–117. 51 indexed citations
15.
Ito, Shinya, et al.. (1999). Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. American Journal of Physiology-Renal Physiology. 277(1). F84–F96. 37 indexed citations
16.
Woodland, Cindy, Douglas L. Blowey, Shinya Ito, Michael Spino, & Gideon Koren. (1998). Hypothetical framework for enhanced renal tubular secretion of drugs in cystic fibrosis. Medical Hypotheses. 51(6). 489–491. 7 indexed citations
17.
Woodland, Cindy, Shinya Ito, & Gideon Koren. (1998). A Model for the Prediction of Digoxin-Drug Interactions at the Renal Tubular Cell Level. Therapeutic Drug Monitoring. 20(2). 134–138. 31 indexed citations
18.
Woodland, Cindy, et al.. (1997). The Digoxin-Propafenone Interaction: Characterization of a Mechanism Using Renal Tubular Cell Monolayers. Journal of Pharmacology and Experimental Therapeutics. 283(1). 39–45. 27 indexed citations
19.
Ito, Shinya, Cindy Woodland, Patricia A. Harper, & Gideon Koren. (1993). P-glycoprotein-mediated renal tubular secretion of digoxin: The toxicological significance of the urine-blood barrier model. Life Sciences. 53(2). PL25–PL31. 26 indexed citations
20.
Ito, Shinya, Cindy Woodland, Patricia A. Harper, & Gideon Koren. (1993). The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1). Life Sciences. 53(24). PL399–PL403. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tauri Senn Breakdown of academic impact, for papers by Hany Ghabrial Breakdown of academic impact, for papers by William Cacini Breakdown of academic impact, for papers by R Pelkonen Breakdown of academic impact, for papers by Sumío Hirata Breakdown of academic impact, for papers by Lance Cope Breakdown of academic impact, for papers by R. A. Smallwood Breakdown of academic impact, for papers by E. W�hlin-Boll Breakdown of academic impact, for papers by Yacoub M. Irshaid Breakdown of academic impact, for papers by Xiao‐cong Zuo
Rankless by CCL
2026